ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,798.24
-0.69%
Gold vs US Dollar
2,356.865
0.21%
Brent Oil
83.78
1.13%
Bitcoin
67,786.32
-2.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pluri Inc (PLUR)

  7. Pluri Inc (PLUR) News

Pluri (PLUR)

Pluri Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLUR
DateTimeSourceHeadlineSymbolCompany
20/05/202412:00GlobeNewswire Inc.Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial ScaleNASDAQ:PLURPluri Inc
09/05/202421:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLURPluri Inc
09/05/202421:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLURPluri Inc
09/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
02/05/202412:00GlobeNewswire Inc.Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer TreatmentNASDAQ:PLURPluri Inc
08/04/202412:00GlobeNewswire Inc.Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New MethodNASDAQ:PLURPluri Inc
28/03/202411:15GlobeNewswire Inc.Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming ConferencesNASDAQ:PLURPluri Inc
27/03/202411:00GlobeNewswire Inc.Pluri Inc. Announces 1-for-8 Reverse Share SplitNASDAQ:PLURPluri Inc
21/03/202411:00GlobeNewswire Inc.Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market ReportNASDAQ:PLURPluri Inc
19/03/202408:00GlobeNewswire Inc.Engage with Pluri's Talent: Exciting Conference Appearances AheadNASDAQ:PLURPluri Inc
14/03/202411:00GlobeNewswire Inc.Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug ManufacturingNASDAQ:PLURPluri Inc
11/03/202411:00GlobeNewswire Inc.Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell CultivationNASDAQ:PLURPluri Inc
06/03/202412:00GlobeNewswire Inc.Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory BoardNASDAQ:PLURPluri Inc
28/02/202412:00GlobeNewswire Inc.Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 GoalsNASDAQ:PLURPluri Inc
14/02/202422:43Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PLURPluri Inc
13/02/202421:34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLURPluri Inc
12/02/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
01/02/202421:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
25/01/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLURPluri Inc
24/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
23/01/202407:00GlobeNewswire Inc.Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee CrisisNASDAQ:PLURPluri Inc
08/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLURPluri Inc
21/12/202312:00GlobeNewswire Inc.Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine AddictionNASDAQ:PLURPluri Inc
13/11/202321:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLURPluri Inc
 Showing the most relevant articles for your search:NASDAQ:PLUR

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
QED
Quadrise
LSE
BP.
Bp
LSE
INSP
Inspirit Energy
LSE
ITV
Itv
LSE
NG.
National Grid
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
BOO
Boohoo
LSE
MIN
Minoan
LSE
SAR
Sareum
LSE
TERN
Tern
LSE
GPL
Graft Polymer (uk)
LSE
EME
Empyrean Energy
LSE
PANR
Pantheon Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved